The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.
All the patients will be evaluated at the baseline, during hospitalization (daily) and at 2 months and 6 months after starting the intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
146
Montelukast 4mg daily for 2 months
Hormozgan University of Medical Sciences (HUMS)
Bandar Abbas, Hormozgan, Iran
Respiratory Distress Severity Score (RDSS)
RDSS is measured by wheezing (0, 1, 2)+ Cough (0, 1, 2)+Retraction (0, 1,2)+Respiratory rate(0,1,2)+ Oxygen saturation(0,1,2) scores
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 days
average number of cough daily= as expressed parents during visits
none= No cough, Mild=less than 10 daily, Severe=More than 10 daily
Time frame: 6 months
Wheezing severity in the physical examination by physician
None= no wheezing, Mild= mild expiratory, Severe= inspiratory and expiratory
Time frame: 6 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.